What’s happening at Sage Therapeutics, Inc. (NasdaqGS:SAGE)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 3.90% (or 2.69 points) to $71.70 from its previous close of $69.01. So is it the right moment to buy?
The shares had a decreased trading volume of 1,372,999 contracts this session compared to the average daily volume of last 10 days of 2,042,775 contracts and they had an increased trading volume compared to the average daily volume of last 3 months of 939,889 contracts.
The indicator of a company’s profitability, the earnings per share ratio is -13.51. This value shows how much money a company makes for each share of its stock. A higher EPS indicates more value because investors will pay more for a company with higher profits. This is negative and tells you exactly how much money the company lost per share of its 51.8M outstanding stock.
The closing market price for this trading session was 26.90% over 52 weeks minimum price of $56.50 and 62.96% under 52 weeks maximum price of $193.56. Also the price is -53.35% less than 200 day average of $153.70 and -42.01% less than 50 day average of $123.65.
Latest news that might have contributed to the great perfomance of SAGE today are:
- Weekly CEO Buys Highlight, published on Mon, 16 Dec 2019 16:28:51 +0000
- Notable Insider Buys In The Past Week: Enterprise Products Partners, PBF Energy, Sage Therapeutics, published on Sat, 14 Dec 2019 19:56:45 +0000
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics, Inc. (SAGE) Investors With 100K+ Losses to Contact Its Attorneys, Securities Fraud Investigation Opened, published on Fri, 13 Dec 2019 01:15:00 +0000